|
|
|
Volumn 152, Issue 4, 2008, Pages
|
|
Mandatory generic substitution continues to be questioned
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTICONVULSIVE AGENT;
GENERIC DRUG;
IMMUNOSUPPRESSIVE AGENT;
LAMOTRIGINE;
AIDS PATIENT;
BIOEQUIVALENCE;
CANCER PATIENT;
DEPRESSION;
DRUG INDUSTRY;
DRUG MONITORING;
DRUG SUBSTITUTION;
EPILEPSY;
GRAFT RECIPIENT;
HEALTH CARE COST;
HUMAN;
HYPERCHOLESTEROLEMIA;
LAW;
MEDICAID;
MEDICAL DECISION MAKING;
MEDICAL SOCIETY;
PATIENT DECISION MAKING;
PHARMACY;
RISK ASSESSMENT;
RISK FACTOR;
SHORT SURVEY;
|
|
EID: 45849107548
PISSN: 00126616
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
